Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims



    Explore by Goal












     Quick Explanation


    Jin-Ha Yoon — evidence-based strengths & gaps
    • From the provided record, their research output appears heterogeneous (e.g., seed cultivation/contaminants; “meridian line” tubular structures; Lipiodol migration; plus a human hs-CRP/MASLD inflammation study). This raises the bar for judging scientific depth because topic-switching can indicate either broad expertise or inconsistent rigor depending on methods and reproducibility.
    • The most directly analyzable quantitative evidence in the provided data is a large cross-sectional hs-CRP study in Korean adults (n=20,141) showing higher hs-CRP in multiple steatotic liver disease subtypes, with cross-sectional limitations on causality.



     Long Explanation


    Author Review: Jin-Ha Yoon
    Status: Evidence-limited — the prompt includes only partial bibliographic/metric data plus one paper’s extracted structured results. I therefore keep conclusions strictly tied to the supplied items and explicitly score uncertainty where appropriate.
    1) Evidence snapshot used in this review
    • Quantitative human data provided: hs-CRP vs steatotic liver disease (MASLD, MetALD, ALD with MD, other SLD) in 20,141 Korean adults (KNHANES 2015–2018), cross-sectional.
    • Author bibliography examples provided (3 items): wild-simulated ginseng seed morphology/physiology + microbial contaminants (in vitro), “tubular structures believed to be meridian line,” and Lipiodol migration along “meridian line.” (These titles are provided, but full methods/results are not included in the prompt.)
    • Bibliometric metrics provided: h-index=1, citations=1, paper count=3 (dataset-provided values; no citation links available in the prompt for these metrics).
    2) Visualized quantitative evidence: hs-CRP across SLD subtypes
    The extracted evidence lists hs-CRP medians with interquartile ranges (mg/L). I visualize those medians and uncertainty bars (IQR-asymmetric) as reported.
    3) Study design strength & the key inference constraint
    • Design: Population-based cross-sectional study using KNHANES (2015–2018), n=20,141 Korean adults; hs-CRP measured by immunoturbidimetry.
    • Strong point: Large sample size relative to many biomarker association studies; clear biological plausibility (hs-CRP as systemic inflammation) and subtype stratification.
    • Major constraint: Cross-sectional data cannot establish whether systemic inflammation precedes steatotic liver disease, or vice versa. The prompt’s extracted “how_to_falsify” framing is consistent: a falsification would require showing hs-CRP does not differ by subtype or that the observed differences are fully explained by confounding.
    4) What this implies about scientific strength (and what it does not)
    • Within the provided hs-CRP study evidence: the author’s contribution (as implied by inclusion in the provided extracted results) aligns with quantitative biomedical association research with explicit limitations acknowledged (cross-sectional design; limited inflammatory panel beyond hs-CRP).
    • Across the provided non-hs-CRP titles: the prompt supplies only titles for seed cultivation microbial-contaminant identification and “meridian line” tubular/Lipiodol migration claims. Because no methods, measurements, controls, blinding, statistical tests, or replication details are included, I cannot responsibly infer scientific rigor for those lines of work from titles alone.
    • Therefore: the most defensible statement from this prompt is about the hs-CRP dataset strength and its interpretive boundaries, not about a broad “track record” across all cited works.
    5) Skeptical critique checklist (how the evidence could mislead)
    • Confounding & correlation: hs-CRP differences by SLD subtype could reflect shared drivers (e.g., adiposity, metabolic risk, infection burden, comorbid inflammation) rather than a causal inflammatory pathway. The prompt itself flags this by noting unmeasured confounding blind spots (diet/lifestyle/genetics).
    • Measurement scope: relying on a single biomarker (hs-CRP) can miss pathway-specific inflammation (e.g., IL-6-driven vs CRP-only downstream effects). This weakens mechanistic inference.
    • Selection bias / generalizability: the cohort is Korean adults from KNHANES; external validity to other populations is uncertain without replication in independent cohorts.
    Run a deeper, tool-based science check
    Because the prompt doesn’t include full text for the other listed works, the most scientifically reliable next step is for an agent to retrieve and extract methods/results from the full papers, then re-score rigor with replication/confounding checks.


    Feedback:    

    Updated: March 22, 2026

     BGPT Author Review


    Scientific Quality

    20%

    The prompt provides only partial evidence: one quantified cross-sectional hs-CRP biomarker association study (methodologically typical for association work but limited for causality) plus several other works only by title. The available non-quantitative titles are insufficient to judge rigor, controls, statistics, or reproducibility. The provided bibliometric metrics (h-index=1, citations=1, 3 papers) are also consistent with either early-career status, under-indexing, or a field with low citation visibility—none of which can substitute for direct methodological evidence. Net: scientific quality cannot be affirmed from the supplied materials; the only concrete evidence is moderate-strength (association study) with known confounding/correlation blind spots.


    Communication Quality

    30%

    No communication text (abstract/intro/conclusion) from the author is provided in the prompt, so communication quality cannot be evaluated beyond noting that extracted study metadata indicates standard reporting of limitations. Net: low confidence due to missing narrative content.


    Author Novelty

    30%

    Novelty cannot be established from only a title list and one extracted study description. The hs-CRP/SLD subtype framing may be incremental depending on whether it introduces new analytical stratification or effect estimation; however, without effect sizes/statistical model details, novelty is not assessable. Net: conservative low-to-mid score due to missing methodological depth.


    Scientific Rigor

    30%

    For the only fully described evidence (hs-CRP cross-sectional KNHANES), rigor appears moderate in design (large N, defined biomarker measurement, acknowledgment of cross-sectional limitation and biomarker scope). But mechanistic rigor remains weak due to causal limits and single-marker inflammation assessment. For other works, rigor cannot be judged from titles alone. Net: overall low-to-moderate rigor with high uncertainty.

     Analysis Wizard



    No bioinformatics computation is appropriate from the provided evidence; instead, it focuses on extracting and plotting reported hs-CRP medians/IQRs and cohort proportions for skeptical, reproducible visual inspection.



     Hypothesis Graveyard


    Claim: “hs-CRP elevation proves hepatic inflammation drives steatosis subtype differences.” Why weaker now: cross-sectional design and single-biomarker measurement allow reverse causation and confounding-driven CRP changes.


    Claim: “hs-CRP tracks a unique, subtype-specific inflammatory mechanism.” Why weaker now: hs-CRP reflects multiple systemic processes; without a broader cytokine/innate immune panel and longitudinal data, subtype specificity is unproven.

     Science Art


    Author Review: Jin-Ha Yoon Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending